TickerFacts.

Amphastar Pharmaceuticals, Inc. (AMPH): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

$222.72M
Year ended 2023-12-31
+123.4%
3-year compound annual growth
2017-12-31: $5.15M2018-12-31: -$2.57M2019-12-31: $7.02M2020-12-31: $19.98M2021-12-31: $80.11M2022-12-31: $120.09M2023-12-31: $222.72M$222.72M
2017-12-31 EBITDA (USD) 2023-12-31
Period endedEBITDAChange YoYSource filing
2023-12-31$222.72M+85.5%2026-02-26, From 2023-01-01
2022-12-31$120.09M+49.9%2025-03-03, From 2022-01-01
2021-12-31$80.11M+300.9%2024-02-29, From 2021-01-01
2020-12-31$19.98M+184.7%2023-03-01, From 2020-01-01
2019-12-31$7.02Mn/m2022-03-11, From 2019-01-01
2018-12-31-$2.57Mn/m2021-03-15, From 2018-01-01
2017-12-31$5.15Mn/a2020-03-16, From 2017-01-01